<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140413017254N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-11-04</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Comparison the effects of different amounts of vitamin D supplementation on calcidiol, Anthropocentric status and body composition in lactation women with body mass index 25 and higher and their infants growth and frequency of visiting a doctor.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the effects of different amounts of vitamin D supplementation on calcidiol, Anthropocentric status and body composition in lactation women with body mass index 25 and higher and their infants growth and frequency of visiting a doctor.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-11-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/34647</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Health service research, Randomization description: Randomization method: Randomize permuted block randomization
 blocks Random unit: Individual
Randomized layers for stratified randomization: for age (under 30 and over 30) and body mass index (below30 and higher than 30)
Randomization Tool: random letters table, Blinding description: How to blind the study: Three types of supplements and placebo will be provided with the same shape, color and size. A person who is not involved in the research team will be required to code for a variety of supplements, such as for the subjects and the researchers not be identified.  At the end of the data collection, the codes of the supplements will be opened.</study_design>
      <phase>N/A</phase>
      <hc_freetext>deficiency of vitamin D in lactating women.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Group 1: Vitamin D supplementation of 2000, IU/d in the form of micro nano capsules from the Nano hayat Pharmacy Company. A daily supplement of 2000 IU/d will be taken as a lunch capsule and a placebo with dinner. Intervention 2: Intervention group: The second group: two vitamins supplementation, 2000 IU/d, in the form of micro nano capsules from the nano-pharmaceutical company. A daily supplement of 2000IU/d will be consumed as a lunch capsule and a supplement of 2000IU/d. Intervention 3: The control group contains of 2000 IU/d   vitamin D placebo in the form of micro nano from nano hayat pharmacy company. A daily dose of 2000 IU/d placebo  will be taken as a lunch capsule and one placebo with dinner.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Because at first the study is all the sample that no data is disseminated</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>zohre gerveieeha</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nutrition, Tehran University Medical Sciences, Naderi St., Keshavar Blvd., Tehran</address>
        <city>qazvin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1439957181</zip>
        <telephone>+98 28 3369 0457</telephone>
        <email>z.gerveiee1989@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Gity Sotodeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nutrition, Tehran University of Medical Sciences, Naderi St., Keshavar Blvd., Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>2188955698</zip>
        <telephone>+98 21 8895 5742</telephone>
        <email>gsotodeh@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 20-49
Mother expresses feeding their infant
Maternal delivery (between weeks 37 and 42)
Body Mass Index (BMI): 25-39.9</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>49 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Detected diseases such as cancer, digestive diseases, diabetes, high blood pressure, liver, kidney, autoimmune diseases, inflammation, thyroid
Changing in diet over the past 3 months
Regular supplementation of vitamin D (at least once a week or supplementing 50,000 units per month) or multivitamins (at least once a week)
Smoking or any smoking, even once a week</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Group 1: Vitamin D supplementation of 2000, IU/d in the form of micro nano capsules from the Nano hayat Pharmacy Company. A daily supplement of 2000 IU/d will be taken as a lunch capsule and a placebo with dinner.</i_keyword>
      <i_keyword>Intervention group: The second group: two vitamins supplementation, 2000 IU/d, in the form of micro nano capsules from the nano-pharmaceutical company. A daily supplement of 2000IU/d will be consumed as a lunch capsule and a supplement of 2000IU/d.</i_keyword>
      <i_keyword>The control group contains of 2000 IU/d   vitamin D placebo in the form of micro nano from nano hayat pharmacy company. A daily dose of 2000 IU/d placebo  will be taken as a lunch capsule and one placebo with dinner.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Calcidiol. Timepoint: Before the intervention, After the intervention. Method of measurement: KIT.</prim_outcome>
      <prim_outcome>PTH. Timepoint: Before the intervention, After the intervention. Method of measurement: KIT.</prim_outcome>
      <prim_outcome>Calcium. Timepoint: Before the intervention, After the intervention. Method of measurement: KIT.</prim_outcome>
      <prim_outcome>Phosphore. Timepoint: Before the intervention, After the intervention. Method of measurement: KIT.</prim_outcome>
      <prim_outcome>Waist Circumference. Timepoint: Before the intervention, After the intervention. Method of measurement: meter-.</prim_outcome>
      <prim_outcome>Height. Timepoint: Before the intervention, After the intervention. Method of measurement: meter.</prim_outcome>
      <prim_outcome>Weight. Timepoint: Before the intervention, After the intervention. Method of measurement: body impedance analysis Inbody270.</prim_outcome>
      <prim_outcome>Fat mass. Timepoint: Before the intervention, After the intervention. Method of measurement: body impedance analysis Inbody270.</prim_outcome>
      <prim_outcome>Fat free mass. Timepoint: Before the intervention, After the intervention. Method of measurement: body impedance analysis Inbody270.</prim_outcome>
      <prim_outcome>Body fat percentages. Timepoint: Before the intervention, After the intervention. Method of measurement: body impedance analysis Inbody270.</prim_outcome>
      <prim_outcome>Fat mass index. Timepoint: Before the intervention, After the intervention. Method of measurement: body impedance analysis Inbody270.</prim_outcome>
      <prim_outcome>Body mass index. Timepoint: Before the intervention, After the intervention. Method of measurement: body impedance analysis Inbody270.</prim_outcome>
      <prim_outcome>Relative fat mass. Timepoint: Before the intervention, After the intervention. Method of measurement: RFM index for women calculated as 76 − (20 height × WC in meters).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Assessment of Neonatal Growth(height, head circumference and weight). Timepoint: Before the intervention, After the intervention. Method of measurement: Data recorded in the case before the intervention and measurements of height, head circumference by meter and weight by scale at the end of the intervention.</sec_outcome>
      <sec_outcome>Frequency of visiting a doctor. Timepoint: Before the intervention, After the intervention. Method of measurement: doctor.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-10-01</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Central Building of Tehran University of Medical Sciences, Ghods st., Keshavarz Blv., Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
